Your browser doesn't support javascript.
loading
Can social prescribing put the 'social' into the biopsychosocial management of people with long-term musculoskeletal disorders?
O'Sullivan, Declan J; Bearne, Lindsay M; Harrington, Janas M; McVeigh, Joseph G.
Afiliação
  • O'Sullivan DJ; Discipline of Physiotherapy, School of Clinical Therapies, College of Medicine and Health, University College Cork, Cork, Ireland.
  • Bearne LM; Population Health Research Institute, St George's, University of London, London, UK.
  • Harrington JM; School of Public Health, College of Medicine and Health, University College Cork, Cork, Ireland.
  • McVeigh JG; Discipline of Physiotherapy, School of Clinical Therapies, College of Medicine and Health, University College Cork, Cork, Ireland.
Musculoskeletal Care ; 21(4): 1341-1352, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37639305
ABSTRACT

BACKGROUND:

Chronic musculoskeletal disorders (MSD) are a significant burden on individuals' quality of life and society and are made more complex by the presence of multimorbidity. It is recommended that interventions targeting MSD be sustainable, equitable and incorporate the biopsychosocial model of care (BPS).

AIMS:

A criticism of the BPS approach is that the social component of this model is not addressed adequately during the management of people with long-term MSD and that a gap exists between theory and implementation. The use of social prescribing (SP) as an intervention to bridge this gap is discussed. RESULTS AND

DISCUSSION:

Social prescribing is a holistic non-medical person-centered approach to well-being that utilizes link workers (LW) to support individuals with long-term conditions (LTC) in the community. Social prescribing referrals are received from primary healthcare practitioners to LW and range from light touch signposting for employment or financial advice to more intensive support for LTC such as obesity, decreased physical activity and mental health needs.

CONCLUSION:

There is evidence to suggest that SP interventions are effective in the management of LTC; however, due to the paucity of high-quality evidence, it is difficult to be conclusive. Large-scale randomised controlled trials are recommended to support the use of SP interventions in the management of LTC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Musculoesqueléticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Musculoskeletal Care Assunto da revista: FISIOLOGIA / ORTOPEDIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Musculoesqueléticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Musculoskeletal Care Assunto da revista: FISIOLOGIA / ORTOPEDIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda